PMID: 8601956Apr 24, 1996Paper

Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling

JAMA : the Journal of the American Medical Association
K Fiscella, P Franks

Abstract

To determine the incremental cost-effectiveness of the transdermal nicotine patch. Decision analytic model that evaluated the incremental cost-effectiveness of the addition of the nicotine patch to smoking cessation counseling. Costs were based on physician time and the retail cost of the nicotine patch, and benefits were based on quality-adjusted life years (QALYs) saved. Male and female smokers aged 25 to 69 years receiving primary care. Addition of the nicotine patch to physician-based smoking cessation counseling. Costs (1995 dollars) per QALYs save discounted by 3% annually. The use of the patch produced 1 additional lifetime quitter at a cost of $7332. The incremental cost-effectiveness of the nicotine patch by age group ranged from $4390 to $10 943 per QALY for men and $4955 to $6983 per QALY for women. A clinical strategy involving limiting prescription renewals to patients successfully abstaining for the first 2 weeks improved the cost-effectiveness of the patch by 25%. The findings provide support both for the routine use of the nicotine patch as an adjunct to physicians' smoking cessation counseling and for health insurance coverage of nicotine patch therapy.

Associated Clinical Trials

Citations

Apr 8, 2014·Bio Systems·F B Agusto, A I Adekunle
Feb 14, 1998·Journal of General Internal Medicine·J S AhluwaliaW S Clark
Mar 17, 1999·American Journal of Public Health·E S FordP L Garbe
Jun 7, 2000·Tobacco Control·T HuM Marciniak
Apr 4, 2002·Journal of General Internal Medicine·Joel F WallaceJoshua J Ofman
Jan 15, 1999·BMJ : British Medical Journal·N Roche
Mar 1, 2005·Tobacco Control·R H Secker-WalkerB S Flynn
May 26, 2005·American Journal of Public Health·Michael K Ong, Stanton A Glantz
Dec 17, 2008·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Nancy Amodei, R J Lamb
May 15, 2009·International Journal of Environmental Research and Public Health·Jennifer W KahendeLatisha Marshall
Sep 2, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Erika D PenzMatthew B Stanbrook
Jan 5, 2011·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Linda BauldRosemary Hiscock
Dec 20, 2011·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Pei-Ching ChenChih-Kuan Lai
Jan 11, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·John A Stapleton, Robert West
Oct 1, 1998·Image--the Journal of Nursing Scholarship·J E Siegel
May 7, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Paul G BarnettAndrew J Saxon
May 16, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Shari P FeirmanAndrea C Villanti
Nov 21, 2007·Current Medical Research and Opinion·Martine HoogendoornMaureen P M H Rutten-van Mölken
Oct 21, 2015·The American Journal of Drug and Alcohol Abuse·Carla López-NúñezRoberto Secades-Villa
Sep 6, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Pamela M McMahonG Scott Gazelle
Apr 25, 2000·Chest·A V Prochazka
Dec 18, 2013·Addiction·Paul G BarnettSharon Hall
Sep 25, 2004·Journal of the American Dietetic Association·Patti S Landers, Thomas L Landers
Dec 7, 2013·Cost Effectiveness and Resource Allocation : C/E·Mark PenningtonSusan M Carr
Jun 17, 2006·American Journal of Preventive Medicine·Leif I SolbergMichael J Goodman
Feb 21, 2006·Journal of Clinical Epidemiology·Christopher A K Y ChongMurray D Krahn
Mar 1, 1997·Preventive Medicine·M A WasleyJ S Ahluwalia
Mar 1, 1997·Preventive Medicine·A M Cheung, J Tsevat
Sep 3, 2002·Journal of the American College of Cardiology·Harlan M KrumholzA David Paltiel
Sep 16, 2004·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Harold S JavitzLisa M Jack
Jan 15, 2004·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Tammy O Tengs
May 10, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Talitha L FeenstraMaureen P M H Rutten-van Mölken
Sep 15, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jennifer Prah RugerKaren M Emmons
Jul 20, 2000·Preventive Medicine·D G JolicoeurC A Moranetz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.